Li Li Author
Subjects of specialization
Affiliation
Cellular Immunology,B cell lymphoma,Oncology,Hematology
Laboratory of Translational Cancer Research, Ochsner Clinic Foundation
Li Li received her MD and Master?s Degree in Immunology from the Shanghai Second Medical University, PhD from the Lübeck Medical University, and her postdoctoral studies at Ochsner Clinic Foundation in New Orleans. She is a Director of Laboratory of Translational Cancer Research and an Associate Director of Laboratory of Cellular Immunology, Ochsner Clinic Foundation. Dr. Li has authored more than 20 papers in peer reviewed journals and shares patent ownership. Her B cell lymphoma studies were supported by various research grants including an R01 NIH grant.
Editorial Open Access
Author(s): Chelsea Grimes, David A. Margolin and Li Li
Are Cancer Stem Cells Responsible for Cancer Recurrence?
Local recurrence or distant organ metastasis are the major causes of cancer mortality. Conventional treatments, including surgery, chemotherapy, and irradiation, do not consistently prevent cancer recurrence. Thus, an alternative therapeutic approach is needed. Recent evidence indicates a specific cell population of cancer stem cells or tumor initiating cells (jointly CSC) exists in various cancers that may be identified by cell surface markers, such as CD133, CD44, aldehyde dehydrogenase 1 (ALDH1) enzyme expression, or side population.
... view more»